These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 10940743)

  • 1. Assessing residual renal function and efficiency of hemodialysis--an application for urographic contrast media.
    Sterner G; Frennby B; Månsson S; Ohlsson A; Prütz KG; Almén T
    Nephron; 2000 Aug; 85(4):324-33. PubMed ID: 10940743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of residual renal function with iohexol clearance in hemodialysis patients.
    Swan SK; Halstenson CE; Kasiske BL; Collins AJ
    Kidney Int; 1996 Jan; 49(1):232-5. PubMed ID: 8770973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of the non-ionic X-ray contrast media iodixanol and iohexol in patients with severely impaired renal function.
    Nossen JO; Jakobsen JA; Kjaersgaard P; Andrew E; Jacobsen PB; Berg KJ
    Scand J Clin Lab Invest; 1995 Jul; 55(4):341-50. PubMed ID: 7569737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of iohexol to quantify hemodialysis delivered and residual renal function: technical note.
    Sacamay TE; Bolton WK
    Kidney Int; 1998 Sep; 54(3):986-91. PubMed ID: 9734627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of radio contrast media on residual renal function in peritoneal dialysis patients--a prospective study.
    Dittrich E; Puttinger H; Schillinger M; Lang I; Stefenelli T; Hörl WH; Vychytil A
    Nephrol Dial Transplant; 2006 May; 21(5):1334-9. PubMed ID: 16046499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiography with nonionic X-ray contrast media in severe chronic renal failure: renal function and contrast retention.
    Jakobsen JA; Berg KJ; Kjaersgaard P; Kolmannskog F; Nordal KP; Nossen JO; Rootwelt K
    Nephron; 1996; 73(4):549-56. PubMed ID: 8856250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Tubular Solute Clearance with Symptom Burden in Incident Peritoneal Dialysis.
    Wang K; Nguyen M; Chen Y; Hoofnagle AN; Becker JO; Zelnick LR; Kundzins J; Goodling A; Himmelfarb J; Kestenbaum B
    Clin J Am Soc Nephrol; 2020 Apr; 15(4):530-538. PubMed ID: 32152064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodialysis clearance of iosimenol, a novel iso-osmolar radiographic contrast medium.
    Hirao Y; Kashiyama E; Umehara K; Kohno M; Ikei N; Hogstrom B
    Acta Radiol; 2014 Oct; 55(8):938-44. PubMed ID: 24123996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal contrast agents for vascular imaging on computed tomography: iodixanol versus iohexol.
    Pannu HK; Thompson RE; Phelps J; Magee CA; Fishman EK
    Acad Radiol; 2005 May; 12(5):576-84. PubMed ID: 15866130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clearance of iohexol, chromium-51-ethylenediaminetetraacetic acid, and creatinine for determining the glomerular filtration rate in pigs with normal renal function: comparison of different clearance techniques.
    Frennby B; Sterner G; Almén T; Chai CM; Jönsson BA; Månsson S
    Acad Radiol; 1996 Aug; 3(8):651-9. PubMed ID: 8796729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of iohexol clearance to determine GFR in patients with severe chronic renal failure--a comparison between different clearance techniques.
    Frennby B; Sterner G; Almén T; Hagstam KE; Hultberg B; Jacobsson L
    Clin Nephrol; 1995 Jan; 43(1):35-46. PubMed ID: 7697934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iso-osmolar radio contrast iodixanol in patients with chronic kidney disease.
    Tadros GM; Malik JA; Manske CL; Kasiske BL; Dickinson SE; Herzog CA; Wilson RF; Das G; Panetta CJ
    J Invasive Cardiol; 2005 Apr; 17(4):211-5. PubMed ID: 15831975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elimination of the nonionic contrast medium iopromide in end-stage renal failure by hemodialysis.
    Kierdorf H; Kindler J; Winterscheid R; Hollmann HJ; Vorwerk D; Speck U
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():119-23. PubMed ID: 2568779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination of iohexol, a low osmolar nonionic contrast medium, by hemodialysis in patients with chronic renal failure.
    Waaler A; Svaland M; Fauchald P; Jakobsen JA; Kolmannskog F; Berg KJ
    Nephron; 1990; 56(1):81-5. PubMed ID: 2234253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodialysis for elimination of the nonionic contrast medium iohexol after angiography in patients with impaired renal function.
    Moon SS; Bäck SE; Kurkus J; Nilsson-Ehle P
    Nephron; 1995; 70(4):430-7. PubMed ID: 7477648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of nephroprotection by the selection of contrast media used during vascular interventions in patients with chronic renal failure?].
    Schönefeld E; Höwler S; Osada N; Torsello G
    Zentralbl Chir; 2011 Oct; 136(5):426-30. PubMed ID: 22009540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma clearance of iodine contrast media as a measure of glomerular filtration rate in critically ill patients.
    Erley CM; Bader BD; Berger ED; Vochazer A; Jorzik JJ; Dietz K; Risler T
    Crit Care Med; 2001 Aug; 29(8):1544-50. PubMed ID: 11505124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iohexol clearance for GFR-determination in renal failure--single or multiple plasma sampling?
    Sterner G; Frennby B; Hultberg B; Almen T
    Nephrol Dial Transplant; 1996 Mar; 11(3):521-5. PubMed ID: 8671824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pool and liver enhancement in CT with liposomal lodixanol: comparison with lohexol.
    Desser TS; Rubin DL; Muller H; McIntire GL; Bacon ER; Toner JL
    Acad Radiol; 1999 Mar; 6(3):176-83. PubMed ID: 10898037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calculation of glomerular filtration rate in conscious rats by the use of a bolus injection of iodixanol and a single blood sample.
    Katayama R; Yamaguchi N; Yamashita T; Watanabe S; Satoh H; Yamagishi N; Furuhama K
    J Pharmacol Toxicol Methods; 2010; 61(1):59-64. PubMed ID: 19854282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.